ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Network Meta-Analysis To Assess The Relative Efficacy And Safety of Linagliptin, Empagliflozin And The Fixed Dose Combination of Empagliflozin And Linagliptin In Patients With Type 2 Diabetes Mellitus (T2DM)
Value in Health
◽
10.1016/j.jval.2016.09.1844
◽
2016
◽
Vol 19
(7)
◽
pp. A667
Author(s):
I Daacke
◽
S Kanters
◽
K Thorlund
◽
A Tebboth
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Meta Analysis
◽
Fixed Dose Combination
◽
Fixed Dose
◽
Relative Efficacy
◽
Efficacy And Safety
◽
Dose Combination
Download Full-text
Related Documents
Cited By
References
Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis
Diabetes Obesity and Metabolism
◽
10.1111/dom.13989
◽
2020
◽
Vol 22
(6)
◽
pp. 1001-1005
Author(s):
Niki Katsiki
◽
Richard Ofori‐Asenso
◽
Ele Ferrannini
◽
Mohsen Mazidi
Keyword(s):
Diabetes Mellitus
◽
Systematic Review
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Meta Analysis
◽
Fixed Dose Combination
◽
Fixed Dose
◽
Dose Combination
Download Full-text
Review for "Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis"
10.1111/dom.13989/v1/review2
◽
2019
◽
Keyword(s):
Diabetes Mellitus
◽
Systematic Review
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Meta Analysis
◽
Fixed Dose Combination
◽
Fixed Dose
◽
Dose Combination
Download Full-text
Decision letter for "Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis"
10.1111/dom.13989/v1/decision1
◽
2019
◽
Keyword(s):
Diabetes Mellitus
◽
Systematic Review
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Meta Analysis
◽
Fixed Dose Combination
◽
Fixed Dose
◽
Dose Combination
Download Full-text
Review for "Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis"
10.1111/dom.13989/v2/review1
◽
2020
◽
Keyword(s):
Diabetes Mellitus
◽
Systematic Review
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Meta Analysis
◽
Fixed Dose Combination
◽
Fixed Dose
◽
Dose Combination
Download Full-text
Author response for "Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis"
10.1111/dom.13989/v2/response1
◽
2020
◽
Author(s):
Niki Katsiki
◽
Richard Ofori‐Asenso
◽
Ele Ferrannini
◽
Mohsen Mazidi
Keyword(s):
Diabetes Mellitus
◽
Systematic Review
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Meta Analysis
◽
Fixed Dose Combination
◽
Author Response
◽
Fixed Dose
◽
Dose Combination
Download Full-text
Decision letter for "Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis"
10.1111/dom.13989/v2/decision1
◽
2020
◽
Keyword(s):
Diabetes Mellitus
◽
Systematic Review
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Meta Analysis
◽
Fixed Dose Combination
◽
Fixed Dose
◽
Dose Combination
Download Full-text
Review for "Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis"
10.1111/dom.13989/v1/review1
◽
2019
◽
Author(s):
BINAYAK SINHA
Keyword(s):
Diabetes Mellitus
◽
Systematic Review
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Meta Analysis
◽
Fixed Dose Combination
◽
Fixed Dose
◽
Dose Combination
Download Full-text
The hypolipidemic and hepatoprotective efficacies of a fixed-dose combination of essential phospholipids with methionine (EPL+M) during atorvastatin (A) therapy in hyperlipidemic patients with cardiovascular diseases (CVD) and type 2 diabetes mellitus (DM) (OLYMP trial)
Endocrine Abstracts
◽
10.1530/endoabs.49.ep598
◽
2017
◽
Author(s):
M G Bubnova
◽
D M Aronov
◽
Marina Bubnoa
◽
David Aronov
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Cardiovascular Diseases
◽
Fixed Dose Combination
◽
Fixed Dose
◽
Dose Combination
◽
Essential Phospholipids
Download Full-text
135-OR: The Effect of Fixed-Dose Combination of Insulin Degludec and Liraglutide on Serum Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus
Diabetes
◽
10.2337/db20-135-or
◽
2020
◽
Vol 69
(Supplement 1)
◽
pp. 135-OR
Author(s):
ELENI PAPPA
◽
CHRISTINA KOSTARA
◽
CONSTANTINOS TELLIS
◽
ALEXANDROS D. TSELEPIS
◽
ELENI BAIRAKTARI
◽
...
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Lipoprotein Metabolism
◽
Serum Lipoprotein
◽
Insulin Degludec
◽
Fixed Dose Combination
◽
Fixed Dose
◽
Dose Combination
Download Full-text
Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus
Expert Opinion on Pharmacotherapy
◽
10.1517/14656566.2013.770839
◽
2013
◽
Vol 14
(4)
◽
pp. 361-370
◽
Cited By ~ 12
Author(s):
Yuri Ono
◽
Hiraku Kameda
◽
Kyu Yong Cho
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Japanese Patients
◽
Fixed Dose Combination
◽
Fixed Dose
◽
Dose Combination
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close